BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 16882753)

  • 1. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
    Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
    Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
    Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
    Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
    Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations.
    Salenave S; Chanson P; Bry H; Pugeat M; Cabrol S; Carel JC; Murat A; Lecomte P; Brailly S; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2008 Mar; 93(3):758-63. PubMed ID: 18160472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Pedersen-White JR; Chorich LP; Bick DP; Sherins RJ; Layman LC
    Mol Hum Reprod; 2008 Jun; 14(6):367-70. PubMed ID: 18463157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
    Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
    Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
    Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GnRH deficiency: new insights from genetics].
    Kottler ML; Hamel A; Malville E; Richard N
    J Soc Biol; 2004; 198(1):80-7. PubMed ID: 15146960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism.
    Xu N; Qin Y; Reindollar RH; Tho SP; McDonough PG; Layman LC
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1155-8. PubMed ID: 17200176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).
    Albuisson J; Pêcheux C; Carel JC; Lacombe D; Leheup B; Lapuzina P; Bouchard P; Legius E; Matthijs G; Wasniewska M; Delpech M; Young J; Hardelin JP; Dodé C
    Hum Mutat; 2005 Jan; 25(1):98-9. PubMed ID: 15605412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated gonadotropic deficiency with and without anosmia: a developmental defect or a neuroendocrine regulation abnormality of the gonadotropic axis.
    de Roux N
    Horm Res; 2005; 64 Suppl 2():48-55. PubMed ID: 16286771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism.
    Bianco SD; Kaiser UB
    Nat Rev Endocrinol; 2009 Oct; 5(10):569-76. PubMed ID: 19707180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
    Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome.
    Tsai PS; Gill JC
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):160-71. PubMed ID: 16932275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular genetics of Kallmann syndrome: an update].
    Fu C; Feng Z; Liu RZ
    Zhonghua Nan Ke Xue; 2011 Apr; 17(4):361-5. PubMed ID: 21548217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical genetics of Kallmann syndrome.
    Dodé C; Hardelin JP
    Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallmann syndrome.
    Dodé C; Hardelin JP
    Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of isolated hypogonadotropic hypogonadism and Kallmann syndrome.
    Karges B; Roux N
    Endocr Dev; 2005; 8():67-80. PubMed ID: 15722618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.